{"id":"https://openalex.org/W1944227239","doi":null,"title":"Cytarabine-resistant leukemia cells are moderately sensitive to clofarabine in vitro.","display_name":"Cytarabine-resistant leukemia cells are moderately sensitive to clofarabine in vitro.","publication_year":2014,"publication_date":"2014-04-01","ids":{"openalex":"https://openalex.org/W1944227239","mag":"1944227239","pmid":"https://pubmed.ncbi.nlm.nih.gov/24692694"},"language":"en","primary_location":{"id":"pmid:24692694","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24692694","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103214812","display_name":"Takahiro Yamauchi","orcid":"https://orcid.org/0000-0002-6531-812X","observed_orcids":["https://orcid.org/0000-0002-6531-812X"]},"institutions":[{"id":"https://openalex.org/I111966504","display_name":"University of Fukui","ror":"https://ror.org/00msqp585","country_code":"JP","type":"education","lineage":["https://openalex.org/I111966504"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takahiro Yamauchi","raw_affiliation_strings":["Department of Hematology and Oncology, Faculty of Medical Sciences, University of Fukui, 23-3 Shimoaizuki, Matsuoka, Eiheiji, Fukui 910-1193, Japan. tyamauch@u-fukui.ac.jp"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Oncology, Faculty of Medical Sciences, University of Fukui, 23-3 Shimoaizuki, Matsuoka, Eiheiji, Fukui 910-1193, Japan. tyamauch@u-fukui.ac.jp","institution_ids":["https://openalex.org/I111966504"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044058543","display_name":"Kanako Uzui","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kanako Uzui","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032574886","display_name":"Rie Nishi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rie Nishi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052902288","display_name":"Hiroko Shigemi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hiroko Shigemi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5011340584","display_name":"Takanori Ueda","orcid":"https://orcid.org/0000-0003-1637-4640","observed_orcids":["https://orcid.org/0000-0003-1637-4640"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Takanori Ueda","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.9914,"has_fulltext":false,"cited_by_count":13,"citation_normalized_percentile":{"value":0.71531264,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"34","issue":"4","first_page":"1657","last_page":"62"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12827","display_name":"Biochemical and Molecular Research","score":0.5092999935150146,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12827","display_name":"Biochemical and Molecular Research","score":0.5092999935150146,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.2296999990940094,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.06310000270605087,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/clofarabine","display_name":"clofarabine","score":0.996999979019165},{"id":"https://openalex.org/keywords/cytarabine-resistance","display_name":"cytarabine resistance","score":0.9950000047683716},{"id":"https://openalex.org/keywords/myeloid-leukemia","display_name":"myeloid leukemia","score":0.8669999837875366},{"id":"https://openalex.org/keywords/nucleoside-transporters","display_name":"nucleoside transporters","score":0.8149999976158142},{"id":"https://openalex.org/keywords/ent1","display_name":"equilibrative nucleoside transporter 1","score":0.9549999833106995},{"id":"https://openalex.org/keywords/deoxycytidine-kinase","display_name":"deoxycytidine kinase","score":0.9940000176429749},{"id":"https://openalex.org/keywords/deoxyguanosine-kinase","display_name":"deoxyguanosine kinase","score":0.9959999918937683},{"id":"https://openalex.org/keywords/hl-60-cells","display_name":"HL-60 cells","score":0.8939999938011169},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.4490000009536743}],"concepts":[{"id":"https://openalex.org/C2777198975","wikidata":"https://www.wikidata.org/wiki/Q5134875","display_name":"Clofarabine","level":4,"score":0.9316315054893494},{"id":"https://openalex.org/C2778041864","wikidata":"https://www.wikidata.org/wiki/Q180983","display_name":"Cytarabine","level":3,"score":0.89519202709198},{"id":"https://openalex.org/C2779268695","wikidata":"https://www.wikidata.org/wiki/Q14914175","display_name":"Deoxycytidine kinase","level":5,"score":0.8570464849472046},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.6001590490341187},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.4912039637565613},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4087839722633362},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3627619743347168},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.34320777654647827},{"id":"https://openalex.org/C2777844706","wikidata":"https://www.wikidata.org/wiki/Q422504","display_name":"Deoxycytidine","level":4,"score":0.24860918521881104},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.24171707034111023},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.19742059707641602},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.18953558802604675},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.15051066875457764},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.05595996975898743}],"mesh":[{"descriptor_ui":"D000077866","descriptor_name":"Clofarabine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000227","descriptor_name":"Adenine Nucleotides","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000227","descriptor_name":"Adenine Nucleotides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000227","descriptor_name":"Adenine Nucleotides","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D001087","descriptor_name":"Arabinonucleosides","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001087","descriptor_name":"Arabinonucleosides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001087","descriptor_name":"Arabinonucleosides","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D003561","descriptor_name":"Cytarabine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D003561","descriptor_name":"Cytarabine","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017853","descriptor_name":"Phosphotransferases (Alcohol Group Acceptor)","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018922","descriptor_name":"HL-60 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D026901","descriptor_name":"Membrane Transport Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D033721","descriptor_name":"Equilibrative Nucleoside Transporter 1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D042541","descriptor_name":"Intracellular Space","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:24692694","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24692694","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"},{"id":"mag:1944227239","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24692694","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W1481284798","https://openalex.org/W1491166067","https://openalex.org/W1769833382","https://openalex.org/W1966417284","https://openalex.org/W1980100889","https://openalex.org/W1984382400","https://openalex.org/W1996844961","https://openalex.org/W2027336282","https://openalex.org/W2049525659","https://openalex.org/W2063226474","https://openalex.org/W2068581230","https://openalex.org/W2089270482","https://openalex.org/W2090466206","https://openalex.org/W2091768197","https://openalex.org/W2110887334","https://openalex.org/W2112998845","https://openalex.org/W2126572589","https://openalex.org/W2129911513","https://openalex.org/W2137967346","https://openalex.org/W2142126731","https://openalex.org/W2148034489","https://openalex.org/W2154101477","https://openalex.org/W2154690456","https://openalex.org/W2155156952","https://openalex.org/W2160635204","https://openalex.org/W2163863527","https://openalex.org/W2165269202","https://openalex.org/W2320674515","https://openalex.org/W2335838520","https://openalex.org/W2584490984"],"related_works":["https://openalex.org/W1991371745","https://openalex.org/W2584490984","https://openalex.org/W2142052119","https://openalex.org/W2057076082","https://openalex.org/W1980572420","https://openalex.org/W2154101477","https://openalex.org/W2790893316","https://openalex.org/W2318613208","https://openalex.org/W2058444707","https://openalex.org/W2321030900"],"abstract_inverted_index":{"BACKGROUND/AIM:":[0],"Clofarabine":[1,148],"is":[2],"transported":[3],"into":[4],"leukemic":[5],"cells":[6,51,63,68,82,153],"via":[7],"the":[8,17,72,80,98,114,130],"equilibrative":[9],"nucleoside":[10,19],"transporters":[11],"(hENT)":[12],"1":[13],"and":[14,16,29,41,64,107,118,124],"2":[15],"concentrative":[18],"transporter":[20],"(hCNT)":[21],"3,":[22],"then":[23],"phosphorylated":[24],"by":[25],"deoxycytidine":[26],"kinase":[27,31],"(dCK)":[28],"deoxyguanosine":[30],"(dGK)":[32],"to":[33,54,88,91,105,136,140,151,157],"an":[34],"active":[35],"triphosphate":[36,99,143],"metabolite.":[37],"Cytarabine":[38],"uses":[39],"hENT1":[40,117],"dCK":[42,119],"for":[43],"its":[44],"activation.":[45],"We":[46],"hypothesized":[47],"that":[48,108,154],"cytarabine-resistant":[49,65],"leukemia":[50,61,152],"retain":[52],"sensitivity":[53],"clofarabine.":[55,146],"MATERIALS":[56],"AND":[57],"METHODS:":[58],"Human":[59],"myeloid":[60],"HL-60":[62,92],"variant":[66],"HL/ara-C20":[67,81,115,131],"were":[69,120,126,155],"used":[70],"in":[71,113,129],"present":[73],"study.":[74],"RESULTS:":[75],"Despite":[76],"20-fold":[77],"cytarabine":[78,102],"resistance,":[79],"exhibited":[83],"only":[84],"a":[85],"6-fold":[86],"resistance":[87],"clofarabine":[89,110],"compared":[90],"cells.":[93,116],"The":[94],"intracellular":[95,142],"concentration":[96],"of":[97,101,109,145],"metabolite":[100,144],"was":[103,111,149],"reduced":[104],"1/10,":[106],"halved":[112],"reduced,":[121],"but":[122],"hCNT3":[123],"dGK":[125],"not":[127],"altered":[128],"cells,":[132],"which":[133],"might":[134],"contribute":[135],"their":[137],"retained":[138],"capability":[139],"produce":[141],"CONCLUSION:":[147],"cytotoxic":[150],"resistant":[156],"cytarabine.":[158]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}